W. McLean Provan
Impact in
- Clinical Biochemistry top 1%
- Metabolism and Genetic Disorders
- Biochemistry top 2%
- Amino Acid Enzymes and Metabolism
Papers in
-
- Metabolism and Genetic Disorders 7
-
- Amino Acid Enzymes and Metabolism 5
- Biochemical Acid Research Studies 2
- Co-authors
- Martin K. Ellis (7 shared papers)Edward A. Lock (7 shared papers)Lewis L. Smith (7 shared papers)Michael P. Prisbylla (3 shared papers)Linda Mutter (3 shared papers)Mervyn Robinson (4 shared papers)David L. Lee (2 shared papers)T.R. Auton (2 shared papers)
- Journals
- Toxicology and Applied Pharmacology (6 papers)Weed Science (1 paper)Journal of Inherited Metabolic Disease (1 paper)Alternatives to Laboratory Animals (1 paper)Xenobiotica (1 paper)
- Partner nations
- United KingdomUnited StatesSweden
In The Last Decade
W. McLean Provan
15 papers receiving 837 citations
Peers
Comparison fields: 5 of 96
- Clinical Biochemistry 263
- Biochemistry 185
- Pharmacology 117
- Pollution 118
- Cancer Research 141
Countries citing papers authored by W. McLean Provan
This map shows the geographic impact of W. McLean Provan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W. McLean Provan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W. McLean Provan more than expected).
Fields of papers citing papers by W. McLean Provan
This network shows the impact of papers produced by W. McLean Provan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W. McLean Provan. The network helps show where W. McLean Provan may publish in the future.
Co-authors
The 25 scholars most cited alongside W. McLean Provan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1997 | 168 | |
| 2 | 1985 | 128 | |
| 3 | 1995 | 95 | |
| 4 | 1998 | 89 | |
| 5 | 2002 | 82 | |
| 6 | 2001 | 76 | |
| 7 | 1996 | 58 | |
| 8 | 1996 | 41 | |
| 9 | 2000 | 32 | |
| 10 | 1996 | 28 | |
| 11 | 2006 | 27 | |
| 12 | 1995 | 27 | |
| 13 | 1998 | 19 | |
| 14 | 1995 | 10 | |
| 15 | 1994 | 2 |
About W. McLean Provan
W. McLean Provan is a scholar working on Clinical Biochemistry, Biochemistry, Molecular Biology, Neurology and Pharmacology, having authored 15 papers that have together received 882 indexed citations. Recurring topics across this work include Metabolism and Genetic Disorders (7 papers), Amino Acid Enzymes and Metabolism (5 papers), Alcoholism and Thiamine Deficiency (3 papers), Carcinogens and Genotoxicity Assessment (2 papers), Biochemical Acid Research Studies (2 papers), Cancer Genomics and Diagnostics (1 paper), Organic Chemistry Cycloaddition Reactions (1 paper) and Alcohol Consumption and Health Effects (1 paper). The work is most often cited by research in Clinical Biochemistry (263 citations), Biochemistry (185 citations), Pharmacology (117 citations), Pollution (118 citations) and Cancer Research (141 citations). W. McLean Provan has collaborated with scholars based in United Kingdom, United States and Sweden. Frequent co-authors include Martin K. Ellis, Edward A. Lock, Lewis L. Smith, Michael P. Prisbylla, Linda Mutter, Mervyn Robinson, David L. Lee, T.R. Auton, Torquil Fraser and Thomas H. Cromartie. Their work appears in journals such as Toxicology and Applied Pharmacology, Weed Science, Journal of Inherited Metabolic Disease, Alternatives to Laboratory Animals and Xenobiotica.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.